KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $154.6 million.

  • Emergent BioSolutions' Operating Expenses fell 3257.74% to $154.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $670.4 million, marking a year-over-year decrease of 4715.02%. This contributed to the annual value of $1.2 billion for FY2024, which is 3510.73% down from last year.
  • Per Emergent BioSolutions' latest filing, its Operating Expenses stood at $154.6 million for Q3 2025, which was down 3257.74% from $139.3 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Operating Expenses registered a high of $630.8 million during Q2 2023, and its lowest value of $139.3 million during Q2 2025.
  • Its 5-year average for Operating Expenses is $321.7 million, with a median of $311.9 million in 2023.
  • Per our database at Business Quant, Emergent BioSolutions' Operating Expenses surged by 10044.49% in 2023 and then crashed by 6959.84% in 2025.
  • Emergent BioSolutions' Operating Expenses (Quarter) stood at $437.9 million in 2021, then dropped by 11.97% to $385.5 million in 2022, then fell by 16.89% to $320.4 million in 2023, then crashed by 36.27% to $204.2 million in 2024, then fell by 24.29% to $154.6 million in 2025.
  • Its Operating Expenses stands at $154.6 million for Q3 2025, versus $139.3 million for Q2 2025 and $172.3 million for Q1 2025.